Profusa (PFSA) Preferred Stock Liabilities (2021 - 2025)
Profusa (PFSA) posted quarterly Preferred Stock Liabilities of $1.3 million for Q2 2025, down 84.44% year-over-year from $8.6 million in Q2 2024, and down 32.89% quarter-over-quarter from $2.0 million in Q1 2025.
Profusa (PFSA) Preferred Stock Liabilities (2021 - 2025) Analysis & Trends
Profusa's Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $1.3 million for Q2 2025.
- In Q2 2025, Preferred Stock Liabilities fell 84.44% year-over-year to $1.3 million; the TTM figure through Jun 2025 stood at $1.3 million (down 84.44% YoY), while the FY2024 annual figure was $13.7 million, up 48.08% from the prior year.
- Preferred Stock Liabilities for Q2 2025 stood at $1.3 million, down from $2.0 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $193.5 million in Q4 2022, with the low at $1.3 million in Q2 2025.
- The 5-year median for Preferred Stock Liabilities is $10.4 million (2023), against an average of $69.6 million.
- The sharpest annual moves came in 2023 and 2024: Preferred Stock Liabilities tumbled 95.22% in 2023, then soared 48.08% in 2024.
- Profusa's Preferred Stock Liabilities stood at $191.6 million in 2021, then gained by 0.98% to $193.5 million in 2022, then sank by 95.22% to $9.3 million in 2023, then jumped by 48.08% to $13.7 million in 2024, then tumbled by 90.29% to $1.3 million in 2025.
- Business Quant data shows PFSA's Preferred Stock Liabilities at $1.3 million in Q2 2025, $2.0 million in Q1 2025, and $13.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Profusa | 92,085.85 | -282,914.15 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.98 Mn |
| Dec 31, 2024 | 13.70 Mn |
| Sep 30, 2024 | 8.14 Mn |
| Jun 30, 2024 | 8.55 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 9.25 Mn |
| Sep 30, 2023 | 10.62 Mn |
| Jun 30, 2023 | 10.38 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 193.53 Mn |
| Sep 30, 2022 | 192.80 Mn |
| Jun 30, 2022 | 191.78 Mn |
| Mar 31, 2022 | 191.65 Mn |
| Dec 31, 2021 | 191.65 Mn |